|
1
|
Peters S, Adjei AA, Gridelli C, Reck M,
Kerr K and Felip E; ESMO Guidelines Working Group, : Metastatic
non-small-cell lung cancer (NSCLC): ESMO clinical practice
guidelines for diagnosis, treatment and follow-up. Ann Oncol.
23:vii56–vii64. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pardal R, Clarke MF and Morrison SJ:
Applying the principles of stem-cell biology to cancer. Nat Rev
Cancer. 3:895–902. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:pp.
3983–3988. 2003; View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hadnagy A, Gaboury L, Beaulieu R and
Balicki D: SP analysis may be used to identify cancer stem cell
populations. Exp Cell Res. 312:3701–3710. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qi W, Zhao C, Zhao L, Liu N, Li X, Yu W
and Wei L: Sorting and identification of side population cells in
the human cervical cancer cell line HeLa. Cancer Cell Int.
14:32014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xie T, Li L, Li DR, Mao NQ, Liu DS, Zuo
CT, Zhang W and Huang DM: Isolation and identification of side
population cells in human lung adenocarcinoma cell line A549.
Zhonghua Zhong Liu Za Zhi. 33:84–90. 2011.(In Chinese). PubMed/NCBI
|
|
14
|
Haraguchi N, Utsunomiya T, Inoue H, Tanaka
F, Mimori K, Barnard GF and Mori M: Characterization of a side
population of cancer cells from human gastrointestinal system. Stem
Cells. 24:506–513. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Szotek PP, Pieretti-Vanmarcke R, Masiakos
PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F,
Maclaughlin DT and Donahoe PK: Ovarian cancer side population
defines cells with stem cell-like characteristics and mullerian
inhibiting substance responsiveness. Proc Natl Acad Sci USA.
103:pp. 11154–11159. 2006; View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Murase M, Kano M, Tsukahara T, Takahashi
A, Torigoe T, Kawaguchi S, Kimura S, Wada T, Uchihashi Y, Kondo T,
et al: Side population cells have the characteristics of cancer
stem-like cells/cancer-initiating cells in bone sarcomas. Br J
Cancer. 101:1425–1432. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou S, Schuetz JD, Bunting KD, Colapietro
AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M,
Nakauchi H and Sorrentino BP: The ABC transporter Bcrp1/ABCG2 is
expressed in a wide variety of stem cells and is a molecular
determinant of the side-population phenotype. Nat Med. 7:1028–1034.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu F, Deng C and Zhang X: Development of
high performance liquid chromatography with immobilized enzyme onto
magnetic nanospheres for screening enzyme inhibitor. J Chromatogr B
Analyt Technol Biomed Life Sci. 871:67–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi MF, Jiao J, Lu WG, Ye F, Ma D, Dong QG
and Xie X: Identification of cancer stem cell-like cells from human
epithelial ovarian carcinoma cell line. Cell Mol Life Sci.
67:3915–3925. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kondo T, Setoguchi T and Taga T:
Persistence of a small subpopulation of cancer stem-like cells in
the C6 glioma cell line. Proc Natl Acad Sci USA. 101:pp. 781–786.
2004; View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang YH, Li F, Luo B, Wang XH, Sun HC, Liu
S, Cui YQ and Xu XX: A side population of cells from a human
pancreatic carcinoma cell line harbors cancer stem cell
characteristics. Neoplasma. 56:371–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chiba T, Kita K, Zheng YW, Yokosuka O,
Saisho H, Iwama A, Nakauchi H and Taniguchi H: Side population
purified from hepatocellular carcinoma cells harbors cancer stem
cell-like properties. Hepatology. 44:240–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Patrawala L, Calhoun T,
Schneider-Broussard R, Zhou J, Claypool K and Tang DG: Side
population is enriched in tumorigenic, stem-like cancer cells,
whereas ABCG2+ and ABCG2-cancer cells are similarly tumorigenic.
Cancer Res. 65:6207–6219. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Croker AK and Allan AL: Cancer stem cells:
Implications for the progression and treatment of metastatic
disease. J Cell Mol Med. 12:374–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hermann PC, Huber SL, Herrler T, Aicher A,
Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations
of cancer stem cells determine tumor growth and metastatic activity
in human pancreatic cancer. Cell Stem Cell. 1:313–323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Karnoub AE, Dash AB, Vo AP, Sullivan A,
Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R and Weinberg
RA: Mesenchymal stem cells within tumour stroma promote breast
cancer metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shimano K, Satake M, Okaya A, Kitanaka J,
Kitanaka N, Takemura M, Sakagami M, Terada N and Tsujimura T:
Hepatic oval cells have the side population phenotype defined by
expression of ATP-binding cassette transporter ABCG2/BCRP1. Am J
Pathol. 163:3–9. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Britton KM, Eyre R, Harvey IJ, Stemke-Hale
K, Browell D, Lennard TW and Meeson AP: Breast cancer, side
population cells and ABCG2 expression. Cancer Lett. 323:97–105.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang B, Ma YF and Liu Y: Elevated
expression of Nrf-2 and ABCG2 involved in multi-drug resistance of
lung cancer SP cells. Drug Res (Stuttg). 65:526–531.
2015.PubMed/NCBI
|
|
30
|
Hirschmann-Jax C, Foster AE, Wulf GG,
Nuchtern JG, Jax TW, Gobel U, Goodell MA and Brenner MK: A distinct
‘side population’ of cells with high drug efflux capacity in human
tumor cells. Proc Natl Acad Sci USA. 101:pp. 14228–14233. 2004;
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ding R, Shi J and Scotto KW: Modulation of
ABCG2 mediated multidrug resistance by xanthine derivatives. Cancer
Res. 71:1746. 2011. View Article : Google Scholar
|
|
32
|
Takara K, Yamamoto K, Matsubara M,
Minegaki T, Takahashi M, Yokoyama T and Okumura K: Effects of
α-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and
transport. PLoS One. 7:e306972012. View Article : Google Scholar : PubMed/NCBI
|
